This inventor holds 1 USPTO granted patent. Top assignee: Gongwin Biopharm Co., Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Longjiang Li: Innovator in Anti-Tumor Pharmaceutical Composition
Introduction
Longjiang Li is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that exhibit anti-tumor activity. His work is crucial in the ongoing battle against cancer, providing new avenues for treatment.
Latest Patents
Longjiang Li holds a patent for a pharmaceutical composition that demonstrates anti-tumor activity. This composition includes para-toluenesulfonamide (PTS) and a pharmaceutically acceptable carrier. It is specifically designed for treating squamous-cell carcinoma. The patent also outlines methods for treating patients suffering from cancer and inhibiting tumor growth.
Career Highlights
Li is associated with Gongwin Biopharm Co., Ltd., where he applies his expertise in pharmaceutical development. His innovative approach has led to advancements in cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Some of his notable coworkers include Nanshan Zhong and Chia-Shun Shih. Their collaborative efforts contribute to the success of their projects and the advancement of cancer therapies.
Conclusion
Longjiang Li's work in developing anti-tumor pharmaceutical compositions represents a significant step forward in cancer treatment. His innovative contributions continue to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile